Tracie Oliver Arrowhead Pharmaceuticals, Inc. (ARWR) insider trading activity

ARWR Quotes by TradingView

Tracie Oliver is Chief Commercial Officer of ARROWHEAD PHARMACEUTICALS, INC.. Currently has a direct ownership of 127,107 shares of ARWR, which is worth approximately $3.19 Million. The most recent transaction as insider was on Jul 02, 2024, when has been sold 9,394 shares (Common Stock) at a price of $25.28 per share, resulting in proceeds of $237,480. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 127K
6.88% 3M change
106.43% 12M change
Total Value Held $3.19 Million

Tracie Oliver Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 02 2024
SELL
Open market or private sale
$237,480 $25.28 p/Share
9,394 Reduced 6.88%
127,107 Common Stock
Jan 05 2024
SELL
Open market or private sale
$2,507 $33.89 p/Share
74 Reduced 0.05%
136,501 Common Stock
Jan 04 2024
BUY
Grant, award, or other acquisition
-
75,000 Added 35.45%
136,575 Common Stock
Jul 03 2023
SELL
Open market or private sale
$315,141 $35.31 p/Share
8,925 Reduced 12.66%
61,575 Common Stock
Jan 04 2023
BUY
Grant, award, or other acquisition
-
500 Added 0.7%
70,500 Common Stock
TO

Tracie Oliver

Chief Commercial Officer
Pasadena, CA

Track Institutional and Insider Activities on ARWR

Follow ARROWHEAD PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARWR shares.

Notify only if

Insider Trading

Get notified when an Arrowhead Pharmaceuticals, Inc. insider buys or sells ARWR shares.

Notify only if

News

Receive news related to ARROWHEAD PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARWR